Withdrawal-induced c-Fos expression in the rat centromedial amygdala 24 h following a single morphine exposure

scientific article

Withdrawal-induced c-Fos expression in the rat centromedial amygdala 24 h following a single morphine exposure is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00213-004-1844-4
P698PubMed publication ID15175841

P2093author name stringTakashi Hamamura
Hiromu Kawasaki
Chunyu Jin
Hiroaki Araki
Katsuya Suemaru
Yutaka Gomita
Kazuhiko Shibata
Mari Nagata
P2860cites workAutonomic areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in ratsQ30465613
The role of the striatopallidal and extended amygdala systems in drug addictionQ33692839
Neurobiology of addiction. Toward the development of new therapiesQ33981470
The effects of LY293558, an AMPA receptor antagonist, on acute and chronic morphine dependenceQ34455963
Neurobiology of opiate abuseQ36208827
Opponent process theory of motivation: neurobiological evidence from studies of opiate dependenceQ38715681
Effect of propranolol on antinociceptive and withdrawal characteristics of morphineQ39070401
Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawalQ41211959
Pharmacologic characterization of the sensitization to the rate-decreasing effects of naltrexone induced by acute opioid pretreatment in rats.Q41229776
Sensitivity to naloxone of the behavioral signs of morphine withdrawal and c-Fos expression in the rat CNS: a quantitative dose-response analysisQ43563196
Induction of the c-fos proto-oncogene during opiate withdrawal in the locus coeruleus and other regions of rat brainQ43807072
The aversive properties of acute morphine dependence persist 48 h after a single exposure to morphine: evaluation by taste and place conditioningQ43921579
Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in ratsQ44015984
Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal.Q44197990
Antagonist-precipitated opioid withdrawal in rats: evidence for dissociations between physical and motivational signsQ44337557
Acute opioid physical dependence in humans: effect of naloxone at 6 and 24 hours postmorphineQ44339185
Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawalQ44341762
Morphine withdrawal precipitated by specific mu, delta or kappa opioid receptor antagonists: a c-Fos protein study in the rat central nervous systemQ44341922
Intracranial self-stimulation in rats: sensitization to an opioid antagonist following acute or chronic treatment with mu opioid agonists.Q44345432
c-Fos and peptide immunoreactivities in the central extended amygdala of morphine-dependent rats after naloxone-precipitated withdrawalQ44574120
Nicotine attenuates place aversion induced by naloxone in single-dose, morphine-treated ratsQ44588959
Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis.Q46316515
A comparison of the effects of naloxone upon body weight loss and suppression of fixed-ratio operant behavior in morphine-dependent ratsQ47330618
The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous systemQ48110278
Effects of acute and chronic morphine treatments on calcium localization and binding in brainQ48193404
Role of the limbic system in dependence on drugsQ48369636
Serotonin1A receptor agonists induce Fos protein expression in the locus coeruleus of the conscious rat.Q48684563
Effects of acute and chronic morphine treatment of calmodulin activity of rat brainQ48908812
Opiate withdrawal-induced fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion.Q49148655
Changes in personality and subjective experience associated with the chronic administration and withdrawal of opiates.Q51334610
Increased fos-like immunoreactivity in the periaqueductal gray of anaesthetised rats during opiate withdrawal.Q51612846
Naloxone-precipitated morphine withdrawal induced place aversions: effect of naloxone at 24 hours postmorphine.Q52183425
Conditioned sucrose aversions produced by naloxone-precipitated withdrawal from acutely administered morphine.Q52191628
Opiate withdrawal signs precipitated by naloxone following a single exposure to morphine: potentiation with a second morphine exposure.Q52197423
Lesions of the dorsomedial amygdala, but not the nucleus accumbens, reduce the aversiveness of morphine withdrawal in rats.Q52212574
Beta-adrenergic antagonists attenuate somatic and aversive signs of opiate withdrawal.Q52221556
A COMPARISON BETWEEN ACUTE AND CHRONIC PHYSICAL DEPENDENCE IN THE CHRONIC SPINAL DOGQ52284675
Modification of precipitated morphine withdrawal syndrome by drugs affecting cholinergic mechanisms.Q52727116
Chronic morphine administration: Plasma levels and withdrawal syndrome in ratsQ58412268
Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversionQ59080348
Acute physical dependence in man: effects of naloxone after brief morphine exposureQ68250786
Effects of phenoxybenzamine on the narcotic withdrawal syndrome in the ratQ70054808
Immediate early gene expression during morphine withdrawalQ70813049
Naloxone-precipitated abstinence in mice, rats and gerbils acutely dependent on morphineQ71241207
NMDA antagonists and clonidine block c-fos expression during morphine withdrawalQ71930968
Acute physical dependence: Time course and relation to human plasma morphine concentrations*Q72113261
Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawalQ73553698
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)428-435
P577publication date2004-10-01
P1433published inPsychopharmacologyQ1422802
P1476titleWithdrawal-induced c-Fos expression in the rat centromedial amygdala 24 h following a single morphine exposure
P478volume175

Reverse relations

cites work (P2860)
Q33709318Acute morphine alters GABAergic transmission in the central amygdala during naloxone-precipitated morphine withdrawal: role of cyclic AMP.
Q36032904Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal
Q42961232CB1 antagonism: interference with affective properties of acute naloxone-precipitated morphine withdrawal in rats
Q64261915Crucial role of feedback signals from prelimbic cortex to basolateral amygdala in the retrieval of morphine withdrawal memory
Q36906676Double Dissociation of Monoacylglycerol Lipase Inhibition and CB1 Antagonism in the Central Amygdala, Basolateral Amygdala, and the Interoceptive Insular Cortex on the Affective Properties of Acute Naloxone-Precipitated Morphine Withdrawal in Rats
Q42157727Effect of glutamate receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats
Q30472657Episodic Withdrawal Promotes Psychomotor Sensitization to Morphine
Q37728136Expression pattern of neural synaptic plasticity marker-Arc in different brain regions induced by conditioned drug withdrawal from acute morphine-dependent rats
Q30537552Proopiomelanocortin (POMC) expression and conditioned place aversion during protracted withdrawal from chronic intermittent escalating-dose heroin in POMC-EGFP promoter transgenic mice
Q30440436Protracted manifestations of acute dependence after a single morphine exposure
Q51894386α7 Nicotinic acetylcholine receptors in the central amygdaloid nucleus alter naloxone-induced withdrawal following a single exposure to morphine.